The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis
- PMID: 19949942
- DOI: 10.1007/s00223-009-9316-9
The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis
Abstract
Observational studies have indicated a high but heterogeneous prevalence of low bone mineral density for adult patients with cystic fibrosis. Fracture complications were also described. The objective of this study was to determine the prevalence of osteoporosis, osteopenia, and fractures among adult patients with cystic fibrosis. A systematic literature review was conducted using electronic databases. The keywords used were "cystic fibrosis [MeSH] AND bone density." Original studies were eligible if they reported the prevalence of osteoporosis and/or osteopenia and/or fractures in adult patients with cystic fibrosis. A meta-analysis of pooled proportions was performed. Heterogeneity was tested with the Cochran Q statistic, and in the case of heterogeneity a random effect model was used. Of 117 studies, 12 were selected, i.e., that represented a total of 1055 patients. Mean age ranged from 18.5 to 32 years (median: 28.2 years). Mean body mass index ranged from 19.9 to 22.4 (median: 20.7); 53.8% were men. The pooled prevalence of osteoporosis in adults with cystic fibrosis was 23.5% (95% CI, 16.6-31.0). The pooled prevalence of osteopenia was 38% (95% CI, 28.2-48.3). The pooled prevalences of radiological vertebral fractures and nonvertebral fractures were 14% (95% CI, 7.8-21.7) and 19.7% (95% CI, 6.0-38.8), respectively. In conclusion, this systematic literature review with meta-analysis emphasized the high prevalence of osteopenia and osteoporosis in young adults with cystic fibrosis. The prevalence of fracture was also high.
Similar articles
-
Prevalence of osteoporosis and osteopenia in men and premenopausal women with celiac disease: a systematic review.Nutr J. 2019 Feb 7;18(1):9. doi: 10.1186/s12937-019-0434-6. Nutr J. 2019. PMID: 30732599 Free PMC article.
-
High prevalence of osteoporosis in patients with chronic pancreatitis: a systematic review and meta-analysis.Clin Gastroenterol Hepatol. 2014 Feb;12(2):219-28. doi: 10.1016/j.cgh.2013.06.016. Epub 2013 Jul 12. Clin Gastroenterol Hepatol. 2014. PMID: 23856359 Review.
-
Bone loss and fracture in people with multiple sclerosis: A systematic review and meta-analysis.Mult Scler Relat Disord. 2024 Oct;90:105773. doi: 10.1016/j.msard.2024.105773. Epub 2024 Jul 15. Mult Scler Relat Disord. 2024. PMID: 39068819
-
Fracture risk and bone health in adrenal adenomas with mild autonomous cortisol secretion/subclinical hypercortisolism: a systematic review, meta-analysis and meta-regression.J Bone Miner Res. 2024 Aug 5;39(7):885-897. doi: 10.1093/jbmr/zjae067. J Bone Miner Res. 2024. PMID: 38703381 Review.
-
Bone loss in adults with cystic fibrosis: prevalence, associated factors, and usefulness of biological markers.Joint Bone Spine. 2012 Jan;79(1):73-7. doi: 10.1016/j.jbspin.2011.05.009. Epub 2011 Jul 5. Joint Bone Spine. 2012. PMID: 21733729
Cited by
-
Auxological and Endocrinological Features in Children and Adolescents with Cystic Fibrosis.J Clin Med. 2022 Jul 13;11(14):4041. doi: 10.3390/jcm11144041. J Clin Med. 2022. PMID: 35887806 Free PMC article. Review.
-
Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideline.Respirology. 2016 May;21(4):656-67. doi: 10.1111/resp.12764. Epub 2016 Apr 18. Respirology. 2016. PMID: 27086904 Free PMC article.
-
A Clinician's guide to vitamin D supplementation for patients with cystic fibrosis.J Clin Transl Endocrinol. 2021 Nov 6;26:100273. doi: 10.1016/j.jcte.2021.100273. eCollection 2021 Dec. J Clin Transl Endocrinol. 2021. PMID: 34815946 Free PMC article.
-
Coming of age in cystic fibrosis - transition from paediatric to adult care.Clin Med (Lond). 2013 Oct;13(5):482-6. doi: 10.7861/clinmedicine.13-5-482. Clin Med (Lond). 2013. PMID: 24115706 Free PMC article. Review.
-
Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.Osteoporos Int. 2016 Apr;27(4):1401-1412. doi: 10.1007/s00198-015-3343-3. Epub 2015 Oct 2. Osteoporos Int. 2016. PMID: 26431978 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical